BMA
Banco Macro SA B ADR
Banco Macro SA B ADR historical holders
total: 2
Oaktree Capital Management Banco Macro SA B ADR transactions over time
- Total transactions:
- 8
- New positions:
- 2
- Sold out:
- 2
- Added:
- 1
- Reduced:
- 3
- Held since:
- 2024 Q1
- Held for:
- 6 quarters
- Latest activity:
- 2025 Q3
Howard Marks has been an institutional investor in Banco Macro SA B ADR (BMA) since 2018 Q2. According to 2026 Q1 report, Howard Marks doesn't hold any shares. The fund/company first acquired BMA in 2018 Q2, initially purchasing 22,306 shares. Howard Marks later completely sold out the position and reinvested in BMA again in 2024 Q1. Since the initial investment, Oaktree Capital Management has made 7 more transactions in this position.
When did Howard Marks exit their BMA position?
Howard Marks no longer holds Banco Macro SA B ADR (BMA). They sold off their entire position in 2025 Q3, closing out an investment that began in 2018 Q2.
When did Howard Marks first invest in BMA?
Howard Marks first invested in Banco Macro SA B ADR (BMA) in 2018 Q2 at the reported quarter-end price of $58.77 per share, acquiring 22,306 shares in their initial purchase.
What is Howard Marks's average cost basis for BMA?
Based on historical transaction data, Howard Marks's estimated cost basis for Banco Macro SA B ADR (BMA) is approximately $48.77 per share. This represents their average reported price* across all buy transactions.
Has Howard Marks reinvested in BMA after selling?
Yes, Howard Marks has shown renewed interest in Banco Macro SA B ADR (BMA). After completely selling their position, they reinitiated an investment in 2024 Q1, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $48.77
- Weighted AVG sell price:
- $76.46
BMA transactions history by Oaktree Capital Management
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q3
|
0.00%
|
0
|
$70.21
|
|
-100% (-60,591)
|
-0.08%
|
|
2025 Q2
|
0.08%
|
60,591
|
$70.21
|
$4,254,094
|
-76.74% (-199,871)
|
-0.29%
|
|
2025 Q1
|
0.40%
|
260,462
|
$75.51
|
$19,667,485
|
-31.21% (-118,163)
|
-0.17%
|
|
2024 Q4
|
0.70%
|
378,625
|
$96.76
|
$36,635,755
|
-18.45% (-85,675)
|
-0.14%
|
|
2024 Q2
|
0.46%
|
464,300
|
$57.33
|
$26,618,319
|
+6.91% (+30,000)
|
+0.03%
|
|
2024 Q1
|
0.34%
|
434,300
|
$48.18
|
$20,924,574
|
new
|
+0.34%
|
|
2018 Q3
|
0.00%
|
$58.77
|
-100% (-22,306)
|
|||
|
2018 Q2
|
0.02%
|
$58.77
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.